The St. Baldrick's Foundation in Monrovia, California, has announced seventy-six grants totaling more than $19.1 million in support of physician-scientists studying innovative treatment options for childhood cancer.
Recipients of grants awarded by the largest private funder of pediatric cancer research in the United States include seven researchers at the Baylor College of Medicine and Texas Children's Cancer and Hematology Centers who will receive grants ranging from $96,012 for research in chemotherapy resistance to $330,000 for a study of biological predictors in Hodgkin's lymphoma in sub-Saharan Africa. Other recipients include researchers at Children's Hospitals and Clinics of Minnesota in Minneapolis; Georgetown Lombardi Comprehensive Cancer Center in Washington, D.C.; and the University of Colorado Anschutz Medical Campus in Aurora.
With this latest round of grants, St. Baldrick's has now awarded more than $253 million in support of childhood cancer research since 2005.
"At St. Baldrick's, we focus on funding research that has the best potential of giving kids the healthy childhoods they deserve," said the organization's CEO, Kathleen Ruddy. "I'm proud to say that we have now funded more than [a] quarter billion dollars since 2005 to support lifesaving childhood cancer research. This achievement would not have been possible without the collective efforts of our amazing volunteers, donors, and supporters across the globe. Together, we are leading the charge to take childhood back from cancer."